Sales to assets ratio of top global pharmaceutical companies 2022

This statistic lines up some of the global top pharmaceutical companies' sales to assets ratio for the year 2022. Novo Nordisk heads the list with a sales to assets ratio of 0.78. This means that for every dollar invested in assets, the company generates nearly 0.8 dollars of revenue in return.

本统计数据显示了2022年全球部分顶尖制药公司的销售与资产比率。诺和诺德位居榜首，其销售与资产比率为0.78。换言之，每投资于资产的一美元，公司可产生近0.8美元的营业收入。